Biomarkers for differential diagnosis of myocarditis, acute coronary syndrome, and sepsis-induced cardiomyopathy
- 1Department of Emergency, The Third People’s Hospital of Chengdu
Abstract
Backgrounds: Diagnosing acute myocardial injury remains a significant challenge in contemporary cardiovascular and critical care medicine. Myocarditis, acute coronary syndrome (ACS), and sepsis-induced cardiomyopathy (SICM) frequently present with overlapping features, chest pain, elevated cardiac biomarkers, and electrocardiographic abnormalities, yet require divergent management, making rapid and accurate etiological diagnosis essential for optimal patient outcomes.
Methods: This narrative review synthesizes current evidence on the pathophysiology and biomarker signatures of myocarditis, ACS, and SICM, and examines how these signatures can be integrated into a practical diagnostic approach for the emergency department and intensive care unit.
Results: High-sensitivity cardiac troponin (hs-cTn) remains the central biomarker of acute myocardial injury, but its kinetics differ across the three conditions. A steep rise and fall in ACS, a sustained moderate elevation in myocarditis, and a gradual, severity-parallel course in sepsis. Among complementary biomarkers, C-reactive protein lacks specificity, whereas procalcitonin supports the recognition of bacterial sepsis in SICM, and natriuretic peptides reflect myocardial wall stress, disproportionately elevated relative to troponin in SICM. Emerging molecular biomarkers, circulating microRNAs (like miR-4763-3p and miR-155) and extracellular matrix remodeling markers, show promise for distinguishing inflammatory from ischemic myocardial injury, but remain investigational owing to the lack of standardized assays and practical constraints on acute bedside use. Therefore diagnosis rests on an integrated, multimodal assessment.
Conclusion: The differential diagnosis of acute myocardial injury requires a systematic, biomarker-centered multimodal approach. Future research should prioritize the prospective validation of multi-biomarker panels and the development of rapid non-invasive tools to reduce reliance on emergency coronary angiography.
Related
- Cardiac Magnetic Resonance-Supported Diagnosis of Acute Myocarditis Mimicking Acute Coronary Syndrome in a Patient With Sepsis Due to a Massive Perianal Abscess
- Massive idiopathic myocardial calcification presenting with a restrictive cardiomyopathy phenotype: diagnostic challenges in the differential diagnosis of constrictive pericarditis
- A Rapid Pathological Diagnosis Based on Unfixed Frozen Tissue Section Leads to the Misdiagnosis of Eosinophilic Myocarditis as Lymphocytic Myocarditis
- The clinical chameleon: eosinophilic myocarditis presenting as acute coronary syndrome-a case report.
- Hypertrophic obstructive cardiomyopathy complicated by severe midventricular obstruction treated with percutaneous transluminal septal myocardial ablation using simultaneous contrast imaging with left ventriculography and coronary angiography: a case report
BibTeX
@article{xiao2026biomarkers,
title = {{Biomarkers for differential diagnosis of myocarditis, acute coronary syndrome, and sepsis-induced cardiomyopathy}},
author = {Yuanyuan Xiao and Tao Xiang},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = oct,
doi = {10.3389/fcvm.2026.1956085},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1956085/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Biomarkers for differential diagnosis of myocarditis, acute coronary syndrome, and sepsis-induced cardiomyopathy
AU - Yuanyuan Xiao
AU - Tao Xiang
PY - 2026
DA - 2026/10/26
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1956085
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1956085/full
AB - Backgrounds: Diagnosing acute myocardial injury remains a significant challenge in contemporary cardiovascular and critical care medicine. Myocarditis, acute coronary syndrome (ACS), and sepsis-induced cardiomyopathy (SICM) frequently present with overlapping features, chest pain, elevated cardiac biomarkers, and electrocardiographic abnormalities, yet require divergent management, making rapid and accurate etiological diagnosis essential for optimal patient outcomes. Methods: This narrative review synthesizes current evidence on the pathophysiology and biomarker signatures of myocarditis, ACS, and SICM, and examines how these signatures can be integrated into a practical diagnostic approach for the emergency department and intensive care unit. Results: High-sensitivity cardiac troponin (hs-cTn) remains the central biomarker of acute myocardial injury, but its kinetics differ across the three conditions. A steep rise and fall in ACS, a sustained moderate elevation in myocarditis, and a gradual, severity-parallel course in sepsis. Among complementary biomarkers, C-reactive protein lacks specificity, whereas procalcitonin supports the recognition of bacterial sepsis in SICM, and natriuretic peptides reflect myocardial wall stress, disproportionately elevated relative to troponin in SICM. Emerging molecular biomarkers, circulating microRNAs (like miR-4763-3p and miR-155) and extracellular matrix remodeling markers, show promise for distinguishing inflammatory from ischemic myocardial injury, but remain investigational owing to the lack of standardized assays and practical constraints on acute bedside use. Therefore diagnosis rests on an integrated, multimodal assessment. Conclusion: The differential diagnosis of acute myocardial injury requires a systematic, biomarker-centered multimodal approach. Future research should prioritize the prospective validation of multi-biomarker panels and the development of rapid non-invasive tools to reduce reliance on emergency coronary angiography.
SN - 2297-055X
ER -